Main
>
ONCOLOGY (**)
>
Head & Neck>Squamous>C.>MET Or R
>
TREAT.:
>
USA. M. PembrolizuMAb
>
Indications>
>
>1st Line Treat.>
>
>MonoTherapy>
>MonoTherapy>'s subsections
>(*) CA Approval Date: 2020. 10.15.
>(*) EU Approval Date: 2019. 11.20
>(*) JP Approval Date: 2019. 12.20
>(*) USA Approval Date: 2019. 06.11
>Companion Diagnostics>
>Tumors Express PD-L1 CPS>1
>MonoTherapy>'s products
This section has no products
>(*) CA Approval Date: 2020. 10.15.
>(*) EU Approval Date: 2019. 11.20
>(*) JP Approval Date: 2019. 12.20
>(*) USA Approval Date: 2019. 06.11
>Companion Diagnostics>
>Tumors Express PD-L1 CPS>1